Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H40N2O6S |
Molecular Weight | 496.66 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 4 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O
InChI
InChIKey=YEESKJGWJFYOOK-IJHYULJSSA-N
InChI=1S/C25H40N2O6S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22(21(28)15-14-17-23(29)30)34-19-20(26)25(33)27-18-24(31)32/h6-7,9-13,16,20-22,28H,2-5,8,14-15,17-19,26H2,1H3,(H,27,33)(H,29,30)(H,31,32)/b7-6-,10-9-,12-11+,16-13+/t20-,21-,22+/m0/s1
Molecular Formula | C25H40N2O6S |
Molecular Weight | 496.66 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 4 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/23859232Curator's Comment: The description was created based on several sources, including
https://www.drugbank.ca/drugs/DB11858 | https://clinicaltrials.gov/ct2/show/NCT01963741 | https://clinicaltrials.gov/ct2/show/NCT02574975 | https://www.ncbi.nlm.nih.gov/pubmed/16149443 | https://www.ncbi.nlm.nih.gov/pubmed/23403082 | https://www.ncbi.nlm.nih.gov/pubmed/17623009 | https://www.ncbi.nlm.nih.gov/pubmed/16042577 | https://www.ncbi.nlm.nih.gov/pubmed/28165820
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23859232
Curator's Comment: The description was created based on several sources, including
https://www.drugbank.ca/drugs/DB11858 | https://clinicaltrials.gov/ct2/show/NCT01963741 | https://clinicaltrials.gov/ct2/show/NCT02574975 | https://www.ncbi.nlm.nih.gov/pubmed/16149443 | https://www.ncbi.nlm.nih.gov/pubmed/23403082 | https://www.ncbi.nlm.nih.gov/pubmed/17623009 | https://www.ncbi.nlm.nih.gov/pubmed/16042577 | https://www.ncbi.nlm.nih.gov/pubmed/28165820
Leukotriene D4 (LTD4, 5(S)-hydroxy-6(R)-S-cysteinylglycyl-7,9,11,14-(E, E, Z, Z)-eicosatetraenoic acid) is a pro-inflammatory mediator produced by eosinophils and mast cells, that is known to mediate its effects through specific cell-surface receptors belonging to the G-protein-coupled receptor family, namely the high-affinity CysLT (cysteinyl leukotriene) receptor. LTD4 is associated with the pathogenesis of several inflammatory disorders, such as asthma and inflammatory bowel disease. LTD4 is triggering many processes central to asthma – mucus secretion, bronchoconstriction and increased vascular permeability. Potent LTD4 antagonists protect (by about 50%) against exercise- and allergen-induced bronchoconstriction, suggesting that leukotrienes contribute to bronchoconstrictor responses. Leukotriene D4 has been used in trials studying the diagnostic of Asthma and Allergic Rhinitis.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1798 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23403082 |
0.7 nM [IC50] | ||
Target ID: CHEMBL4330 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23859232 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01963741
Nasal provocation test was induced by leukotriene D4 with a stepwisely concentration method (4 mcg/ml, 8 mcg/ml, 16 mcg/ml).
Route of Administration:
Nasal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24141567
Mouse microglial cell line BV2, transfected with hCysLT1R or hCysLT2R were used for activity evaluation. Cells were seeded on 35-mm Petri dishes at a density of 1.5×10^5 cells/dish. LTD4 (0.01–100 nmol/L) was added to the culture for 3 h in the presence or absence of CysLT receptor antagonists. One hour before cell harvest, fluorescent microspheres (red, diameter 1 μm, Invitrogen) were added at a density of 6×10^7 particles/dish. The cells were then washed thoroughly with PBS containing 1% bovine serum albumin and detached by trypsinization. Then, the cells were quenched with 1% FBS and subjected to FACScan analysis using a FC500MCL flow cytometer (Beckman Coulter Inc, USA). Fluorescence intensity was detected in the FL-2 channel (564–606 nm) and reflected the phagocytic activity of the cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:06:39 GMT 2023
by
admin
on
Fri Dec 15 15:06:39 GMT 2023
|
Record UNII |
5FNY4416UE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
28666
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY | |||
|
73836-78-9
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY | |||
|
5FNY4416UE
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY | |||
|
C180700
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY | |||
|
m6777
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY | Merck Index | ||
|
63166
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY | |||
|
DB11858
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY | |||
|
5280878
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY | |||
|
Leukotriene D4
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY | |||
|
DTXSID6040533
Created by
admin on Fri Dec 15 15:06:39 GMT 2023 , Edited by admin on Fri Dec 15 15:06:39 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Binding Assay
IC50
|